Pioneering Cell Therapy Partnerships and Solutions.

Syed T. Husain leads Made Scientific as Chairman and Chief Executive Officer, bringing deep expertise across the CDMO spectrum, from development to commercialization of both established and emerging therapeutic modalities. His strategic vision blends operational excellence with bold innovation to advance breakthrough cell therapies. 

Throughout his distinguished career, Syed has guided organizations through transformative growth and market disruption. Prior to Made Scientific, as Chief Commercial Officer at Resilience, he built a world-class commercial organization spanning cell and gene therapies, biologics, vaccines, and nucleic acids, establishing a multi-billion-dollar opportunity pipeline through strategic partnerships. His leadership roles at Emergent BioSolutions, Alcami Corporation, and Lonza sharpened his expertise in commercial strategy and operations. Syed began his career in manufacturing compliance at Wyeth before advancing through validation, product development, and manufacturing leadership positions at Pfizer. 

Syed holds a Master of Business Administration from Cornell University's Johnson Graduate School of Management and a Bachelor of Science in Chemical Engineering from the New Jersey Institute of Technology, where he serves on the Industrial Advisory Board for the Otto H York Department of Chemical Engineering. His industry leadership includes chairing the Education Committee and serving on the Advisory Council for the Drug, Chemical & Associated Technologies Association, alongside active involvement in the Biotechnology Innovation Organization, Society of Biological Engineers, American Institute of Chemical Engineers, and American Chemical Society. Syed’s leadership is driven by bold innovation and challenging industry norms to create a CDMO model that accelerates scalability, enhances flexibility, and ensures manufacturing readiness for groundbreaking therapies.

Sun Ra Bullins brings over two decades of biopharmaceutical operations expertise to his role as Vice President and Head of Technical Operations at Made Scientific. A proven leader in GMP manufacturing, Sun Ra specializes in process optimization and seamless project execution that ensures client success. 

Throughout his career, Sun Ra has established a reputation for building and optimizing manufacturing facilities with precision and foresight. At Excellos, he spearheaded the design and construction of a 10,000 ft² GMP cell therapy production facility featuring multiple ISO 7 cleanrooms—delivering the infrastructure that enabled breakthrough therapies to reach patients. His leadership experience at industry leaders including Catalent Pharma Solutions, Samsung Biologics, and Genentech has honed his ability to build high-performing teams united by a commitment to safety, quality, and innovation. 

Sun Ra holds a Bachelor of Science in Biology from California State University and remains passionate about translating scientific advances into real-world manufacturing solutions that serve patients.

With more than 25 years of experience spanning cell therapy and biologics, Ck Harinarayan serves as Vice President and Head of Quality & Compliance at Made Scientific. Her multifaceted expertise across quality systems, development, and technical operations allows her to foster a culture where compliance and innovation work in harmony. 

Most recently as Head of Clinical GMP Quality at Kite Pharma, Ck implemented phase-appropriate quality systems that supported groundbreaking cell therapies while guiding CMC product quality strategy across the clinical pipeline. Her career highlights include scaling multiple GMP facilities and navigating regulatory pathways that led to the successful commercialization of Yescarta® and Tecartus® cell therapies. Ck's meticulous approach to quality has resulted in over 25 successful regulatory inspections and internal audits—a testament to her unwavering commitment to excellence. 

Ck holds a Bachelor of Science in Chemical Engineering from Birla Institute of Technology and Science and a Master of Science in Chemical Engineering from Colorado State University. She approaches each project with the conviction that robust quality systems are the foundation of transformative medicine.

David Smith, Ph.D., leads Development at Made Scientific, overseeing Manufacturing Science & Technology (MS&T), Process Development, and Analytical Method Development with the insight that comes from 15+ years of regenerative medicine and cell therapy manufacturing experience. 

Prior to joining Made Scientific, David served as Vice President of Technical Operations at Ori Biotech, where he crafted strategies that shaped Ori's pioneering cell therapy manufacturing technology platform. His leadership at Minaris Regenerative Medicine produced process innovations that continue to influence the field today. David's commitment to advancing industry standards is evident through his active leadership roles within organizations including ISCT, ARM, ISO, ASME, and PDA. 

With a Ph.D. in Regenerative Medicine from Loughborough University, David combines scientific rigor with practical manufacturing expertise. He champions quality-by-design principles and data-driven approaches that transform promising therapies into reproducible manufacturing processes—ultimately connecting breakthrough science with patient care.

Joe Sinclair directs commercial strategy and client partnerships as Vice President and Head of Commercial at Made Scientific, bringing over 15 years of experience in scaling CDMO operations for advanced therapeutics. 

Before joining Made Scientific, Joe served as Senior Vice President of US Operations and GMP Site Head at uBriGene Biosciences, where he successfully launched cell therapy manufacturing solutions that addressed critical market needs. His strategic leadership roles at Recipharm/Vibalogics, WuXi Advanced Therapies, and WuXi AppTec have equipped him with valuable insights into building lasting client relationships founded on transparency and collaboration. 

Joe holds a Bachelor of Science in Business Administration with a concentration in Pharmaceutical and Healthcare Marketing from Saint Joseph's University. He approaches each client partnership with the understanding that behind every manufacturing project lies the potential to transform patient lives.

As Senior Director and Head of Human Resources at Made Scientific, Ria S. Barrett leads people-centered strategies that enable our technical excellence. Her 15+ years of HR leadership across life sciences, legal, and professional services sectors inform her holistic approach to talent management and organizational development. 

Most recently at Lantheus Medical Imaging, Ria implemented talent frameworks that supported business growth while fostering an inclusive workplace culture. She recognizes that behind every manufacturing success is a team of dedicated professionals whose expertise and commitment drive innovation. 

Ria holds an MBA in Human Resources from Nyack College and a Bachelor of Arts in Business Administration with a concentration in HR Management from Adelphi University. She believes that cultivating an environment where scientific talent can thrive is essential to delivering on Made Scientific's promise to clients and, ultimately, to patients. 

Henry Han guides financial strategy and operational efficiency as Senior Director and Head of Finance at Made Scientific. With more than 15 years in financial management, Henry brings valuable expertise in corporate finance, M&A, and operational excellence to the company's growth initiatives. 

Prior to Made Scientific, Henry served as Financial and Accounting Team Leader at Ubcare Co. Ltd., where he managed post-merger integration following the company's $200 million acquisition by GC. His experience as Finance Team Manager at Green Cross Holdings Corporation included overseeing corporate bond issuances and governance practices that established financial stability. 

Henry holds a Bachelor's degree in Business Administration from Chung-Ang University in Seoul, Korea. He approaches financial management with the understanding that sound fiscal practices create the foundation for scientific innovation and reliable manufacturing partnerships.